Medical Industry News Archive

Click here to search our archive

Print using browser

URGENT MEDICINE RECALL: SANDOZ CEFPODOXIME 40mg/5ml Reg No A39/20.1.1/0397 (50ml and 100ml pack sizes)
Sandoz SA (Pty) Ltd in collaboration with the Medicines Control Council are initiating a Class 2, Type B recall on all batches of Sandoz Cefpodoxime 40mg /5ml (50ml and 100ml pack sizes).

Sandoz Cefpodoxime 40mg/5ml powder for oral suspension is an antibiotic used for short- term treatment of lower and upper respiratory tract infections in infants, children and adults.

The product is being recalled due to lower than expected efficacy, high unknown impurities, discolouration and formation of brownish agglomerates on certain batches of Sandoz Cefpodoxime 40mg/5ml tested during stability monitoring.

Use of the product may lead to weakened patient therapy through insufficient anti-infective treatment resulting in: a patient being contagious to others for a longer time, the development and spread of resistant bacterial strains, and significant therapeutic difficulties in eradication of respective bacteria.

In the interest of patient safety, Sandoz SA (Pty) Ltd request that you immediately return all batches of Sandoz Cefpodoxime 40mg/5ml stock without delay to your supplying wholesaler or distributor for full credit.
Sandoz SA (Pty) Ltd would like to thank you for your co-operation and apologise for any inconvenience caused.

Should you have any enquiries in this regard kindly contact the Sandoz Customer Call Centre 0861 SANCAL or 0861 726 225 during office hours and a technical support 24 hour call no 0768114744.

For full prescribing information please refer to package insert approved by Medical Regulatory Authority

Sandoz SA (Pty) Ltd PO Box 154, Isando 1600 Kempton Park, Gauteng South Africa Tel Fax +27 (0) 11 394 3084    Reg No: 1990/001979/07
Directors: R-A Bassoul (Canadian) J-C Dubos (French) M.M Paleja (Singaporean)  
A Novartis Company

You need to be logged in to see more details. Register Now!

Click here for more information .....
Contact: Carla Urbani-Smith, (Responsible Pharmacist)
Telephone: +27 (0) 11 929 9000
Date: Tuesday, February 14, 2012

Archive News Headlines
Biogaran - launch - PREXUM 5 mg/ PREXUM 5 mg PLUS (perindopril arginine/ perindopril arginine + indapamide)
Aspen/GlaxoSmithKline - Stock Shortage - Flixotide 500 Accuhaler (fluticasone propionate 500 µg)
Genop Healthcare - launch - Xailin Fresh Eye Drops and Xailin Night Lubricating Eye Ointment
Mundipharma launch Teejel Gel 10 g (Choline salicylate 87,1 mg, Ethanol 96% 38,2% m/m)
Novartis – Stock Outage of Ritalin 10mg capsules (methylphenidate hydrochloride)
Orphan SA Pharmaceuticals (Pty) Ltd - Stock Shortage – Ursofalk 250mg Capsules (ursodeoxycholic acid)
Pfizer - Price Reduction: Xalacom (latanoprost and timolol maleate) Eye Drops and Xalatan (latanoprost) Eye Drops
Aspen - Stock Outage - Tenchlor HS Tablets (atenolol, chlorthalidone)
Alcon launch Systane Lid Wipes
Pharmaco Distribution - Stock Outage - Akineton Tablets (biperiden 2mg)
Aspen - Stock Outage - NeoMercazole 5mg (carbimazole)
Aspen - Stock Availability - Normison 20mg Capsules (temazepam)
Pfizer - Stock Shortage - Valoron 50mg/ 5ml Drops 10ml (tilidine hydrochloride semi-hydrate)
Janssen Pharmaceutica discontinue Jurnista 4mg Oral Tablets (hydromorphone)
Cipla - Stock Outage - Lexamil 5mg tablets (Escitalopram)
Aspen - Stock shortage - Flixonase Aqueous Nasal Spray (fluticasone propionate)
Atka Pharma launches BioBalance Immunova+ Throat Spray 30ml (Carbohydrate Derived Fulvic Acid)
Alcon launch Systane Gel Drops
Novartis South Africa (Pty) Ltd - discontinue - Zaditen® 1 mg (Ketotifen) tablets
Takeda - Stock Shortage - Legalon Tablets (silymarin)